Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PharmaJet develops and commercializes needle-free jet injection systems (Tropis for intradermal and Stratis for intramuscular/subcutaneous delivery) used globally in routine and campaign immunization programs, including polio, and as enabling delivery for partners’ DNA/RNA vaccines and immunotherapies; their devices have U.S. FDA 510(k) clearance (Stratis), CE Mark, and WHO PQS prequalification and have been used in tens of millions of injections worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PharmaJet.